GlassScriptPhysician profile
Emily C Bagby
NPI 1720277270
$1,397.78
in general payments reported to CMS, 2019-2025
20 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $467 · 2022: $364 · 2023: $151 · 2024: $224 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $557.58 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $117.72 | 2021-2024 | |
| Amgen INC. | $115.50 | 2021-2025 | Evenity, Prolia, Prolia |
| Seqirus USA INC | $76.83 | 2022-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Astellas Pharma US INC | $64.34 | 2023-2024 | Veozah |
| Dexcom, INC. | $59.76 | 2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $50.88 | 2022-2025 | Zepbound, Mounjaro |
| Jazz Pharmaceuticals INC. | $45.03 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $44.81 | 2021 | |
| Glaxosmithkline, LLC. | $34.79 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $33.07 | 2022 | |
| Merck Sharp & Dohme LLC | $31.57 | 2021 | |
| Sanofi Pasteur INC. | $29.93 | 2021-2023 | |
| Exact Sciences Corporation | $28.90 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $26.74 | 2023-2025 | Breztri, Flumist Quadrivalent |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $20.76 | 2022 | |
| Hologic Sales and Service, LLC | $18.65 | 2024 | Aptima |
| Takeda Pharmaceuticals U.S.A., INC. | $16.43 | 2021 | |
| Amarin Pharma, INC. | $12.71 | 2021 | |
| Paratek Pharmaceuticals, INC. | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Bagby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.